Onco, Drugs and Markers Flashcards
Alkylating Agents
CELL CYCLE NON-SPECIFIC DRUGS (CCNS) Crosslink DNA, Lipids, and Carbs with Methyl groups.
Cyclophosphamide Melphalan Chlorambucil
Nitrogen Mustard Alkylating agents. CCNS Tx: Hodgkins/Non-Hodgkins Lymphoma SEs: GI, Myelosuprresion, alopecia, sterility, Vescication, secondary malignancies
Cyclophosphamide: CHOP Regiment for CLL, neuroblastoma, rhabdomosarcoma, breast/ovarian, soft tissue sarcoma. Hemorrhagic Cystitis** (and bladder cancer)
Melphalan: Multiple myeloma, breast cancer, ovarian cancer.
Chlromabuicl: CLL and NHL
ThioTEPA
Arizidine type Alkylating Agent (CCNS) Breast, Ovarian, and superficial bladder cancer SEs: Myelosupression
Carmustin Lomustin Stretozocin
Nitrosoureas type Alkylating Agent (CCNS)
CNS Use (Lipid Soluable). SEs: Myelosuppresion, Interstitial Lung Disease, Interstial Nephritis
Busulfan
Alkyl Sulfonate type Alkylating Agent (CCNS)
CML
PULM FIBROSIS****, skin pigmentation , adrenal insufficiency
Mechlorethamine
Alkylating Agent (CCNS) Hodgkins and NLH VESICANT******, GI distress, myelosuprresion, alopecia
Procarbazine Dacarbazine Bendamustine
Nonclassical Alkylating Agents (CCNS) Procarbazine: Highest risk of secondary cacners. Metabolites act as MOA Dacarbazine: potent VESICANT Bendamustine: Nasuea vomtiging, myelosurpession
Platinum Analogs
DNA crosslinkers, synergist effects with alkylating agents, flouropyrimidines and taxanes. Hydration issues
Carbopaltin Cisplatin Oxaliplatin
Can be given concurrently to reduce tox?
CCNS Carboplatin: No hydration issues, fever renal and GI tox Cisplatin: Irreversible peripheral neuropathies Oxaliplatin (part of FOLFOX)–REVERSIBLE peripheral neuropathies
Amifostine: Free radical scavenging agent decreasing cumulative nephrotox
AntiMetabolites
CCS in S phase Goal is to disrupt DNA precursor production/synth
Methotrexate Pemetrexed
Antifolate type antimetabolite CCS Methotrexate hits DHFR and thymidylate synthase. Rescue with Leucovorin Pemetrexed: Thymidlate synthase inhibitor
5-fluororuracil Capecitabine
Prodrog antimetablite CCS 5-flourouracil: DHPD converts to FdUMP inhibiting dna synth of thymine (thymineless death) and FUTP (inhibiting RNA processing and translation). Patients lacking DHPD get severe tox. Capecitaine: Fluoropyridine prodrug. SEs: Hand foot syndrome
Cytarabine Gemcitabine
Deoxycitidine Pyrimide Analog Antimetabolite (CCS) Cytarabine: RAPID CLEARANCE–continous IV infusion, hematological malignancies (AML first line drug)–makes sense since maintain a high concentration in blood but not anywhere else dt clearance. Gemcitiabine: Inhibits RBR thus inhibiting DNA pol, DNA syth/repair, causing Chain term. BROAD cancer tx, SEs: Neutropenia and Renal Microangiopathy.
6-mercaptopurine Cladribine 6-thiopurine Fludarabine
Purine antagonist type antimetabolite (CCS) 6-mercaptopurine–metabolixed by HPRT. SEs: Def of TPMT causes toxicity which is exacerbated with Allopurinol Cladribine: Immunosupression of CD4/8 T-cells
Vinblastine Vincristine
Vinca Alkyloid (CCS) Microtubule destabilizers arresting cell in mitosis (no spindle assembly). Vinblastine–vessicant (BLAST forms BLISTERS, and used for BONE marrow)
Vincristine: Neurotox w/ peripheral neuropathy, SIADH, ANS dysfunction
Paclitaxel Abraxane Docetaxel Ixebepilone
Taxane class (CCS) Microtbuule stabilizers, cleared by Cyp 450s Paclitaxel–breast, ovarian (solid tumors) SEs: Hypersensitivy and neurotoxicities Abraxane–Paclitaxel with albumin to prevent hypersensitivity Ixebepilone: Nontaxane. Binds Beta-tubulin subunits causing stabilization
Etoposide
Teniposide
Epipodophylotoxins CCS Etoposide: Inhbits Topoisomerase 2**. SEs: HOTN, myelosupresion, alopecia, nausea, vomitiging
Topotecan Irinotecans
Camptothecans (CCS) Inhibits Topoisomerase I Irinotechan: Prodrug. COLORECTAL CANCER first line (“irin-to the butt”). Diarrhea (first dt cholinergic stim, then more severe from toxicity)
Doxorubicin (adriamycin) Daunorubicin Idarubicvin Epirubicin Mitoxantrone
Anthracyline type drugs CCNS** Hodgkins 1) Inhibit Topoisomerase II, 2) DNA intercalation, 3) Semiquinone free-radical production (causes cardiac tox), 4) Binding to cell membranes (altering fluidity, and ion transport) CARDIAC TOX (arrythmias and conduction abnormalities progressing to dilated cardiomyopathy)
Mitomycin C
CCNS Prodrug. HEMOLYTIC UREMIC SYNDROME
Bleomycin
CCS drug inhibitng G2 phase by binding DNA. Hodkins and testicular cancer. PULM FIBROSIS from progressive pneumonitis
Prednisone
Glucocorticoid. Causes Apoptosis of immune cells (early on during low dose it will actually cause marrow release of myeloid/lymphoid cells into blood)
Tamoxifen
Estrogen antagonist in breast, estrogen agonist in ovaries/uterus. SEs: prothrombotic state, endometrial hyper/neoplasia.
Flutamide
Androgen Receptor Antagonists used in prostate cancer. Given initially before GnRH agonists as they initially cause an increase in GnRH levels.
Leuprolide, Goserelin, Nafarelin
GnRH analogs: Prostatic carcinomas Acute doses increase LH/FSH levels Chronic doses: lowers LH/FSH lvls
Anastrozole
Aromatase Inhibitors. Used for advanced breast cancer by lowering estrone levels
Imatinid Dastinib Nilotinib
tx for CML t(9;22). Inhibitors bcl-abl fusion kinase Dastinib–multi kinase inhibitor nilotinib–higher specificity for bcl-abl kinase both are newer and used when imatinib doesn’t work
Trastuzamab (herceptin)
Inhibits HER-2/neu receptor (EGFR) in breast cancer Adverse Rxns: CARDIAC TOX (CHF (LVFailure)), and pulm toxicity
Cetuximab Panitumumab
Metastaic colon cancer. Inhibits extracelullar domain of EGFR. KRAS expressing cancers. Acneiform skin rash and hypomagnesmia SEs
Gefitinib Erlotinib
Moleclar inhibitors of the tyrosine kianse domain of EGFR. Non-small cell lung cancer.
Bevacibzumab Sorafenib Sunitinib
VEGF inhibitor. Metastaic Colorectal cacner, non-small lung cancer, and breast cacner Bevacibzumab:HTN increased incidence of arterial thromboembolic events (TIA, stroek, agnina, MI) Sunitinib: Advanced Renal cell cacner
Sirolimus, Tacrolimus, Tensirolimus, Everolimus
MTOR inhibitors (inhibit calcineurin) preventing T-cell formation
Bortezomib (velcade)
Boron containing molecule inhibitng proteasome, causing a pro-apoptosis, cell death effect. Works well for refractory cancers. SEs: Peripheral neuropathies
Rituximab (rituxan)
AntiCD20 Antibody—inhibits B-cells Lymphomas and Rheumatoid arthritis
Gemtuzumab ogozomicin
Anti-CD33 antibody
Alemtuzumab
AntiCD52 antibody
Aspariginase
Childhood ALL. Tumor cells lack asparagine synthesase, and this drug depletes asparagine which means inhibition of protein synth SEs: Hypersentivitiy. Bronchospasm resp failure and HTON
Alkaline Phosphatase
Mets to bone, liver, Pagets disease of bone
Seminoma (from placental ALP)
Alpha Feto Protein
Hepatocellular Carcinoma, Hepatoblastoma
Yolk Sac (endodermal sinus) tumor
Testicular Cancer
Mixed germ cell tumor (w/ BhCG)
CA-15-3
Breast Cancer
CA-27-29
Breast
CA-19-9
Pancreatic Adenocarcinoma
CA-125
Ovarian Cancer
Calcitonin
Medullary Thyroid Carcinoma (MEN2a/b)
CEA
CarcinoEmbryonic Antigen
70% of colorectal and panc
Can be produced by Gastric, breast, medullary thyroid carcinomas
S-100
Nerual Crest Origin (melanomas, neural tumors, schwannomas, langerhans cell histiocytosis)
TRAP
Hairy Cell Leukemia (b cell neoplasm)
Adult have blood smear with B-cells having filamentous projections. Dx? Stain? Tx? Mechanism?
Hairy Celly Leukemia.
TRAP +
Cladribine (2-CDA): adeonsine analog that inhibits ADA
AFP?
HCC, Yolk sac tumor (endodermal sinus), Mixed germ cell tumors
Pancytopenia with:
1) Fatty inflitrate on bone marrow
2) Hepatosplenomegaly and fibrosis on bone marrow
3) Dissordered differentaiton on bone marrow (possible ringed sideroblasts and megaloblastic anemia)
4) Bone marrow being crowded out by tumor with some fibrosis
1) Aplastic Anemia
2) Myelofibrosis
3) Myelodysplastic syndrome
4) Myelophthisic anemia
Follate deprivation can be rescued somewhat by supplementing what?
Thymidine: allowing thymidine kinase to replete some of the dTMP stores
Irradiation does what?
1) Double Strand DNA breaks
2) Forms free radicals
ALL B vs T markers/presentation?
Special about Tx?
TDT+ (marker of pre T and pre B cells)
CD10+ (PreB cells only)
T cell will tend to present with mediastinal mass (inspiratory stridor/dysphagia)
B-ALL tx: treat their B-rains and B-alls (need chemo that passes thru the BBB, and Testis Blood barrier)
Difference between SLL and CLL?
SLL is the same as CLL except that CLL has peripheral blood lymphocytosis or bone marrow involvement. (SLL=small lymphocytic LYMPHOMA, CLL is chronic lymphocytic leukEMIA)
Both are found in 60+ yo. CD20+ 5+. Smudge Cells
Aplastic Anemia
Myleofibrosis
Myelodysplastic syndrome
Myelophthisic anemia
Aplastic: Failure/destruction of myeloid SCs, usually dt offending agent/virus. PANCYTOPENIA with FATTY INFLITRATION (Dry bone tap). NO HSM
Myelofibrosis: HSM*** dt chronicity (think of Aplastic progressing to this). Atypical megakaryocyte activation results in fibroblast activation=fibrosis
Myelodysplastic=ineffective hemaotpoesis (DYSplastic NOT aplastic). Pancytopenia/or decrease in 1 cell type. Marrow shows disordered differentation
Myelophthisic Anemia; Space occupying lesion of bone marrow (mets associated with fibrosis)
Difference between Leukemoid Rxn and CML?
Both will have increased WBC counts with left shift (more band cells).
Leukemoid will have increased Leukocyte ALP (“these are functional WBCs”) vs CML will have decreased Leukocyte ALP (non-functional cancerous type cells)
Translocations for what cancer and what gene is overexpressed:
t(11;14)
t(14;18)
t(8;14)
t(15;17); Tx?
t(9;22) Tx?
t(11;22)
1) Mantle (think of the 1’s forming a mantle for 4 and D1)
2) Folicular Lymphoma (bcl-2), and DLBCL
3) Burkitt Lymphoma (c-myc)
4) Promyelocytic Leukemia (altered Retinoic Acid receptor that does not respond, thus the cell never gets the signal to differentate and stays as a blast), Auer Rods, ATRA (retinoic Acid)
5) Philadelphia chromo (bcr-abl fusion protein) tx with imatinib (SMALL MOLECULE (not antibody) tyrosine kinase inhibitor)
6) Ewing’s Sarcoma (11+22=33)
Bilateral carpal tunnel with macroglossia in elderly male?
Multiple Myeloma (amyloid deposition in the median nerve and tongue)
DD btwn Waldenstrom’s Macroglobinemia and Multiple Myeloma?
What do you see on urinalysis with MM?
Both will have hypervisocity sxs and M spikes. However Waldenstrom’s will NOT have lytic bone lesions.
NOTHING on urinalysis, you see bence jones proteins on Urine Protein Electrophoresis
Old man presenting with easy fatiguabilty, constipation, bone pain and renal failure
Multiple Myeloma (anemia, hypercalcemia, axial bone pain from increased RANKL + IL1, Renal failure)
Can have associated neurosxs from hyperviscosity syndrome
Paraneoplastic Cerebellar Degeneration associated with which antibodies?
Anti-
Yo (ovary/breast)
P/Q (Lung)
Hu (Lung)
Methotrexate
Inhibits what? Rescue? SEs? Antipyrimidine or purine?
Folic acid analog inhibiting DHFR
Can recuse with leucovorin or Thymidine (increases the salvage pathway)
Anti-pyrimidine
5-FU
Inhibits what? Rescue? SEs? Antipyrimidine or purine?
Pyrimidine analog activated to 5F-dUMP.
5F-dUMP complexes with folic acid to inhibt thymidylate synthase.
NOT reversible. Can tx an OD with Uridine
Cytarabine
Inhibits what? Rescue? SEs? Antipyrimidine or purine?
Pyrimidine analog inhibiting DNA poly
CYTarabine causes panCYTopenia
No rescue
Azathioprine
Inhibits what? Rescue? SEs? Antipyrimidine or purine?
Metabolized by HGPRT into an active form of 6-MP
Anti-Purine de novo synth inhibitor
Inactivated by Xanthine oxidase THUS ALLOPURINOL causes toxicity
Dactinomycin?
MOA? SEs? Clinical Use?
Also know as Actinomycin D
Intercalates DNA (D-act-IN-omycin=gets IN DNA)
SEs: Myelosuprresion
Used for Wilms tumor, Ewing sarcoma, rhabdommyosarcoma, CHILDHOOD TUMORS***
“ONION SKIN GROWTH OF BONE”
Anthracyclins
Drug Names? MOA? SEs? Prevention of SEs? Clinical Use?
Doxorubicin (Adriamycin), Daunorubicin
Free Radicals, Intercalates into DNA causing breaks and decreased replciation.
SEs: CARDIOTOXICITY (dilated cardiomyopathy), Myelosuppression, alopecia.
Dexrazoxane can be given to chelate iron and prevent cardiotox.
Used for Solid tumors, leukemias and lymphomas
Bleomycin
MOA? SEs? Clinical Use (know this–step 1 likes to ask)?
Induces free radical formation causing DNA strand breaks
PULM FIBROSIS, skin changes mucositis; minimal myelosuppression
Used for Testicular cancer (B-leo is for your B-alls), hodgkins lymphoma
Cyclophosphamide
MOA? SEs? Clinical Use? Rescue?
Covalently cross links at Guanines.
“Makes DNA cyclic=cyclo-phosphamide”
HEMORRHAGIC CYSTISIS
Mesna: thiol group binds toxic metabolites
Nitrosoureas
MOA? SEs? Clinical Use? Examples?
Carmustine, Lomustine, semustine, Streptozocin
(-mustines: “Put NITRO in your MUSTang”)
Crosses BBB and crosslinks DNA (needs bioactivation)
Used for Brain tumors; has CNS toxicity (convulsions/dizziness, ataxia)
Busulfan
MOA? SEs? Clinical Use?
Cross-links DNA
CML and bone marrow ablation before transplant.
Thus SEs are severe myelosuppression; PULM FIBROSIS*****, hyperpigmentation
Vinca alkaloids
2 examples? MOA? SEs? Clinical Use? What phase do they inhibit?
VinCristine CNS toxicity
Vin_B_lastine _B_one marrow suppression
Inhibits microtubule by binding to the BETA tubulin unit
M phase arrest
Used for solid tumors, leukemias and lymphomas
Taxanes
MOA? SEs? Clinical Use?
Microtubule HYPERSTABILIZER preventing mitotic spindle from breaking down in M phase thus no anaphase
Used in ovarian and breast cancer
Platinum Compounds
2 Examples? MOA? SEs? Clinical Use? Rescue?
“-platins” Carboplatin, Cisplatin
Cross-links DNA
NEPHROTOXICITY and acoustic Nerve damage.
Can prevent npehrotox with amifostine (free radical scavenger)
Used in testicular bladder ovarian and lung cancers
Topoisomerase II inhibitors
2 examples? MOA? SEs? Clinical Use?
Etoposide, Teniposide (“-SIDES” inhibit Topo II)
Myelosuppression, GI irritation and alopecia
Topoisomerase I inhibitors
2 examples? MOA? SEs? Clinical Use?
Irinotecan, Topotecan
Coloncancer (irinotecan–2 forms of GI issues—secretory diarrhea followed by true GI tox). Ovarian and small cell lung cancers (topotecan)
Myelosuprresion
Trastuzumab Tox?
Cardiotox (“HEARTceptin” for herceptin)
“_T_rastuzumab for _T_itties which close to the heart”
Vemurafenib
MOA, Clinical use?
Small Molecule inhibitor of B-raf kinase with V600E mutation
Bevacizumab
MOA, SEs
beV**acizumab anti-**Vegf
Hemorrhage and imparied wound healing
Myelodisplastic and myeloproliferative disorders tend to progress to?
AML
Tumor Supressor mutations associate with which cancer?
p16
DPC
DCC
p16=melanoma
DPC=Panc Cancer (“D-eleted in P-anc C-ancer)
DCC=Colon Cancer (“D-eleted in C-olon C-ancer)
Oncogene mutations in the following
KRAS
HRAS
NRAS
C-MYC
L-MYC
N-MYC
ERB2
KRAS: K-olon, panKreatic, lung
HRAS: Bladder and kidney (“h for hematuria”)
NRAS: melanoma and hematologic malignancies (and follicular thyroid)
C-MYC: burCits
L-MYC: Lung (Small cell carcinoma)
N-MYC: Neuroblastoma (which is a tumor of the ADRENALS)
ERB2: Breast, Ovarian and Gastric
Testicular Cancer drugs?
EBC: Eradicate Ball Cancer
Etoposide, Bleomycin, Cysplatin
Two drugs with Pulm Fibrosis—what are their mechanism of actions?
Bleomycin: Fragments DNA by inducing free radical damage
Busulfan: Cross links DNA
Difference between Sirolimus vs Cyclosporin/Tacrolimus
Sirolimus binds mTOR and has minimal nephrotox
Cyclo/Tacro inhibit IL-2 thru calcineurin and have hepatotox